Emerging peptide and neuroendocrine strategies for TRT-induced reproductive suppression and functional male hypogonadism: a narrative review
Frontiers in Reproductive Health · 14.08.2026 · 8
DOI: 10.3389/frph.2026.1914709 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Reproductive Health, online erschienen am 14.08.2026. Verfasst von Ana-Maria Cretu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Origyn Fertility Center, Iași, România. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The growing burden of male hypogonadism has raised concerns regarding the potential impact of modern lifestyles and environmental exposures on male reproductive health. Testosterone replacement therapy (TRT) is widely used for the treatment of male hypogonadism. However, prolonged TRT may suppress the hypothalamic-pituitary-testicular (HPT) axis, resulting in reduced gonadotropin production, decreased intratesticular testosterone levels, impaired spermatogenesis, testicular atrophy, and compromised fertility. Current management strategies, including human chorionic gonadotropin (hCG), follicle-stimulating hormone (FSH), and selective estrogen receptor modulators (SERMs), can support recovery in some patients, but their effectiveness remains variable. This narrative review examines the emerging role of peptide and neuroendocrine strategies in TRT-induced reproductive suppression and functional male hypogonadism. A structured literature search was conducted to identify experimental, translational, and clinical studies investigating reproductive peptides and related neuroendocrine pathways. Particular attention was given to kisspeptin-based therapies, gonadotropin-releasing hormone (GnRH)-related approaches, neurokinin signaling pathways, and other developing interventions with potential relevance to male reproductive health. Current evidence suggests that peptide-based therapies may support endogenous hormonal signaling through targeted activation of the HPT axis. However, direct evidence demonstrating restoration of spermatogenesis or fertility following TRT-induced suppression remains limited, and important questions regarding long-term efficacy, safety, treatment protocols, and patient selection remain unresolved. Emerging peptide therapeutics represent a growing area of interest in reproductive endocrinology and may expand future treatment options for selected patients. Nevertheless, further well-designed clinical studies are required to establish their long-term efficacy, safety, and role in restoring reproductive function following TRT-induced suppression.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Origyn Fertility Center, Iași, România.
- Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy Iasi, Iași, Romania.
- Department Biology, Faculty of Biology, Doctoral School, Alexandru Ioan Cuza University, Iași, Romania.
- Department Biology, Faculty of Biology, Alexandru Ioan Cuza University (UAIC), Iași, Romania.
- Department of Urology, "Dr. C.I. Parhon" Clinical Hospital, Iași, Romania.
- Spitalul Clinic de Obstetrică și Ginecologie "Cuza Vodă", Iași, Romania.
Zitieren
APA
Cretu, A. M., Kamar, A. A. M., Ciobica, A., Puia, D., Doroftei, M., & Doroftei, B. (2026). Emerging peptide and neuroendocrine strategies for TRT-induced reproductive suppression and functional male hypogonadism: a narrative review. Frontiers in Reproductive Health, 8. https://doi.org/10.3389/frph.2026.1914709
Vancouver
Cretu AM, Kamar AAM, Ciobica A, Puia D, Doroftei M, Doroftei B. Emerging peptide and neuroendocrine strategies for TRT-induced reproductive suppression and functional male hypogonadism: a narrative review. Frontiers in Reproductive Health. 2026;8. doi:10.3389/frph.2026.1914709
BibTeX
@article{Cretu2026,
author = {Cretu, Ana-Maria and Kamar, Ahmed Adel Mansour and Ciobica, Alin and Puia, Dragos and Doroftei, Mara and Doroftei, Bogdan},
title = {Emerging peptide and neuroendocrine strategies for TRT-induced reproductive suppression and functional male hypogonadism: a narrative review},
journal = {Frontiers in Reproductive Health},
year = {2026},
volume = {8},
doi = {10.3389/frph.2026.1914709}
}
EUVIMED